Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIg for Painful Sensory Neuropathies in Primary Sjögren's Syndrome
NCT03700138Phase 3Completed
- Sponsor
- Strasbourg University Hospital
- Start
- Jun 2019
- Primary completion
- Apr 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of intravenous immunoglobulin G in primary Sjögren's syndrome, sponsored by Strasbourg University Hospital. Started Jun 2019; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
primary Sjögren's syndrome
Beyond the preview
Go deeper on NCT03700138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03700138.